The COMP gene helps make a protein that supports cartilage, tendons, and ligaments, so bones and joints develop with the right shape and strength. This gene plays an important role in normal growth and joint stability. If the COMP gene does not work properly, it can cause pseudoachondroplasia or multiple epiphyseal dysplasia, conditions that affect bone growth and may lead to short stature, joint pain, loose joints, and early arthritis.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for producing proteins, the functional parts of cells. Others mainly help determine when certain processes happen, where they occur, and how strongly they operate. Taken together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. To explore this topic in more detail, you can learn more in the LearnHub.
Overview
COMPGene function
What if the gene works
The COMP gene helps make a protein that supports cartilage, tendons, and ligaments. It helps these tissues stay organized and resilient, especially in joints that bear weight and absorb repeated pressure.
Risk
What if the gene does not work
Variants in the COMP gene can disrupt bone and joint growth, causing pseudoachondroplasia or the milder multiple epiphyseal dysplasia, with short stature, limb changes, and early joint pain. Milder or more severe variants can shift onset and severity.
Treatment
What does that mean for your treatment
No COMP-specific treatment or drug choice is currently established for people with a pathogenic variant in the COMP gene. The COMP gene is being studied mainly as a biomarker in cartilage conditions such as osteoarthritis, rather than as a current target for gene-directed therapy.
Conditions associated with COMP
Gene function
What if the gene works
Smooth movement depends on strong cartilage and well-organized connective tissue. In these tissues, the COMP gene helps build the supportive material outside cells that gives joints, tendons, and ligaments their shape and spring. When it works as expected, these tissues can better handle everyday bending, walking, and weight bearing.
The COMP gene helps make the extracellular matrix (the support material around cells) in cartilage and related tissues. Its protein becomes part of this framework and helps surrounding cells sit in a sturdy, flexible environment.
Inside the tissue space, COMP helps collagen fibers line up and assemble into strong bundles. This helps explain COMP gene function in cartilage, where smooth, resilient structure matters for daily movement.
By organizing the matrix, COMP supports tissues that face repeated pressure and pulling, such as joint cartilage, tendons, and ligaments. This gives these tissues a balanced mix of strength, flexibility, and cushioning.
What is a variant?
A genetic variant is a slight difference in the DNA sequence within a gene. These differences are common and help account for normal human diversity, such as variation in appearance, metabolism, or the way the body responds to environmental influences. Many variants have no noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant changes how a gene works more substantially and may contribute to, or directly cause, a genetic condition.
Genetic variants
What if the gene does not work
Variants in the COMP gene often change the shape of the COMP protein, so it folds poorly, gets trapped inside cartilage cells, or binds less well to the surrounding tissue. This explains how COMP gene variants affect cartilage at a cellular level. Milder variants may leave some protein activity, while more severe variants can cause greater protein buildup and cell stress, which often links to earlier or more marked skeletal changes.
How variants are linked to conditions
Pathogenic variants in the COMP gene are a well-established cause of pseudoachondroplasia and some cases of multiple epiphyseal dysplasia, both conditions that affect bone growth and joints. In people looking up COMP gene variants linked to skeletal conditions, these are the main diagnoses supported by clinical genetics research. Pseudoachondroplasia usually involves more marked short stature and joint looseness, while multiple epiphyseal dysplasia related to the COMP gene is often milder and may present with hip, knee, or ankle pain and early osteoarthritis.
A variant is not necessarily a diagnosis
Gene variants are a normal feature of human biology and are widely present in the general population. Most have no direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definitive diagnosis, especially when more than one gene and environmental factors are involved. In some instances, though, a single well characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For COMP, risk is mainly tied to whether a disease-causing variant was inherited, so family history is the main factor. There is not enough evidence to say that lifestyle changes lower the chance of developing a COMP-related bone growth condition. Early diagnosis, regular follow-up, and joint care can still help limit complications.
Inheritance of COMP variants
COMP-related conditions are usually inherited in an autosomal dominant pattern. This means a parent with a disease-causing variant in the COMP gene has a 50% chance of passing it to each child. In families asking how COMP gene variants are inherited, the usual pattern is that one altered copy is enough to cause the condition. Some people have a new, de novo variant in the COMP gene, which means it started in them and was not inherited from either parent.
What does my COMP result mean for my family?
For well-known COMP-related conditions, the family pattern is usually dominant, so close relatives such as a parent, brother, sister, or child may also carry the same gene change. Each child of someone with a disease-causing COMP change has a 1 in 2, or 50%, chance of inheriting it. Some COMP changes happen new in a child, so a parent is not always the source.
Genetic information
Genetic testing
How you find out about variants
To find out about variants, doctors order genetic testing for COMP gene variants using a blood or saliva sample. Most labs use sequencing, which reads the COMP gene letter by letter and looks for changes. Results may show a pathogenic variant, a benign variant, or a variant of uncertain significance.
When should I consider getting a genetic test?
Consider COMP testing if you or your child has short stature, joint pain, a waddling walk, or early hip, knee, or ankle problems that suggest an inherited bone growth condition. It can also help when these features run in the family or when X-rays show changes at the ends of the bones.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it reveals depends on the condition and the type of variant. Many factors, including lifestyle, environment, age, and medical history, affect how the body functions over time. In some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. A treatment that works well for one person may work less well for another, or may cause more side effects, because the body can absorb, break down, or respond to a drug differently. These inherited differences are common and can influence both how well a medicine helps and how sensitive someone is to it.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes affect the way medications work. It studies gene and drug patterns to help explain why the same treatment can have different effects in different people. For many drugs, genes influence both how the body handles a medicine and how strong its effects are. This information can support more informed and more personalized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the COMP gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or used, so any concerns about symptoms, side effects, or treatment are best discussed with your doctor.
History
The COMP gene entered medical genetics through research on families with inherited bone growth conditions, especially pseudoachondroplasia and multiple epiphyseal dysplasia. In the early 1990s, scientists linked variants in the COMP gene to these conditions, helping explain why some families shared joint problems, short stature, and early osteoarthritis across generations. Initially understood only through visible traits, later recognized as tied to a specific gene, this discovery marked an important step in skeletal genetics. From these first observations, research expanded steadily. As more families were studied, doctors learned that different COMP gene variants could be associated with a range of severity. This work helped move diagnosis from description alone to more precise genetic confirmation.